TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Modalis Therapeutics Corporation ( (JP:4883) ) just unveiled an update.
Modalis Therapeutics Corporation announced a non-operating expense of 35 million yen due to foreign exchange losses for the first half of 2025. This financial impact was primarily due to the revaluation of foreign currency denominated assets and liabilities, which may affect the company’s earnings as detailed in their financial results.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a company listed on the Tokyo Stock Exchange, focusing on the biotechnology industry. It specializes in developing innovative therapies, with a market focus on genetic and molecular treatments.
Average Trading Volume: 5,097,750
Technical Sentiment Signal: Sell
Current Market Cap: Yen7.08B
For a thorough assessment of 4883 stock, go to TipRanks’ Stock Analysis page.